United Kingdom (UK) Hereditary Angioedema Therapeutic Market (2025-2031) | Trends, Analysis, Value, Share, Size & Revenue, Forecast, Industry, Growth, Segmentation, Companies, Competitive Landscape, Outlook
Market Forecast By Type (Type I Hereditary Angioedema (HAE), Type II Hereditary Angioedema (HAE), Type III Hereditary Angioedema (HAE)), By Drug Class (C-1 Esterase Inhibitors, Bradykynin B2 Receptor Antagonist, Kallikrein Inhibitors, Others), By Application (Prophylaxis, Treatment), By Route of Administration (Oral, Injectable) And Competitive Landscape
| Product Code: ETC9946055 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
Key Highlights of the Report:
- United Kingdom (UK) Hereditary Angioedema Therapeutic Market Outlook
- Market Size of United Kingdom (UK) Hereditary Angioedema Therapeutic Market, 2024
- Forecast of United Kingdom (UK) Hereditary Angioedema Therapeutic Market, 2031
- Historical Data and Forecast of United Kingdom (UK) Hereditary Angioedema Therapeutic Revenues & Volume for the Period 2021- 2031
- United Kingdom (UK) Hereditary Angioedema Therapeutic Market Trend Evolution
- United Kingdom (UK) Hereditary Angioedema Therapeutic Market Drivers and Challenges
- United Kingdom (UK) Hereditary Angioedema Therapeutic Price Trends
- United Kingdom (UK) Hereditary Angioedema Therapeutic Porter's Five Forces
- United Kingdom (UK) Hereditary Angioedema Therapeutic Industry Life Cycle
- Historical Data and Forecast of United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume By Type for the Period 2021- 2031
- Historical Data and Forecast of United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume By Type I Hereditary Angioedema (HAE) for the Period 2021- 2031
- Historical Data and Forecast of United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume By Type II Hereditary Angioedema (HAE) for the Period 2021- 2031
- Historical Data and Forecast of United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume By Type III Hereditary Angioedema (HAE) for the Period 2021- 2031
- Historical Data and Forecast of United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume By Drug Class for the Period 2021- 2031
- Historical Data and Forecast of United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume By C-1 Esterase Inhibitors for the Period 2021- 2031
- Historical Data and Forecast of United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume By Bradykynin B2 Receptor Antagonist for the Period 2021- 2031
- Historical Data and Forecast of United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume By Kallikrein Inhibitors for the Period 2021- 2031
- Historical Data and Forecast of United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume By Others for the Period 2021- 2031
- Historical Data and Forecast of United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume By Application for the Period 2021- 2031
- Historical Data and Forecast of United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume By Prophylaxis for the Period 2021- 2031
- Historical Data and Forecast of United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume By Treatment for the Period 2021- 2031
- Historical Data and Forecast of United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume By Route of Administration for the Period 2021- 2031
- Historical Data and Forecast of United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume By Oral for the Period 2021- 2031
- Historical Data and Forecast of United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume By Injectable for the Period 2021- 2031
- United Kingdom (UK) Hereditary Angioedema Therapeutic Import Export Trade Statistics
- Market Opportunity Assessment By Type
- Market Opportunity Assessment By Drug Class
- Market Opportunity Assessment By Application
- Market Opportunity Assessment By Route of Administration
- United Kingdom (UK) Hereditary Angioedema Therapeutic Top Companies Market Share
- United Kingdom (UK) Hereditary Angioedema Therapeutic Competitive Benchmarking By Technical and Operational Parameters
- United Kingdom (UK) Hereditary Angioedema Therapeutic Company Profiles
- United Kingdom (UK) Hereditary Angioedema Therapeutic Key Strategic Recommendations
Frequently Asked Questions About the Market Study (FAQs):
6Wresearch actively monitors the United Kingdom (UK) Hereditary Angioedema Therapeutic Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United Kingdom (UK) Hereditary Angioedema Therapeutic Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Hereditary Angioedema Therapeutic Market - Industry Life Cycle |
3.4 United Kingdom (UK) Hereditary Angioedema Therapeutic Market - Porter's Five Forces |
3.5 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about hereditary angioedema (HAE) and its treatment options |
4.2.2 Advances in medical research leading to the development of innovative therapies |
4.2.3 Growing prevalence of HAE in the UK population |
4.3 Market Restraints |
4.3.1 High costs associated with HAE therapeutic treatments |
4.3.2 Limited availability of specialized healthcare facilities for HAE patients in certain regions |
5 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Trends |
6 United Kingdom (UK) Hereditary Angioedema Therapeutic Market, By Types |
6.1 United Kingdom (UK) Hereditary Angioedema Therapeutic Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume, By Type I Hereditary Angioedema (HAE), 2021- 2031F |
6.1.4 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume, By Type II Hereditary Angioedema (HAE), 2021- 2031F |
6.1.5 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume, By Type III Hereditary Angioedema (HAE), 2021- 2031F |
6.2 United Kingdom (UK) Hereditary Angioedema Therapeutic Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume, By C-1 Esterase Inhibitors, 2021- 2031F |
6.2.3 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume, By Bradykynin B2 Receptor Antagonist, 2021- 2031F |
6.2.4 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume, By Kallikrein Inhibitors, 2021- 2031F |
6.2.5 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Kingdom (UK) Hereditary Angioedema Therapeutic Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume, By Prophylaxis, 2021- 2031F |
6.3.3 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume, By Treatment, 2021- 2031F |
6.4 United Kingdom (UK) Hereditary Angioedema Therapeutic Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenues & Volume, By Injectable, 2021- 2031F |
7 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Export to Major Countries |
7.2 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Imports from Major Countries |
8 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Key Performance Indicators |
8.1 Number of clinical trials focused on HAE therapies in the UK |
8.2 Patient adherence rates to prescribed HAE treatments |
8.3 Number of healthcare professionals trained in managing HAE cases |
9 United Kingdom (UK) Hereditary Angioedema Therapeutic Market - Opportunity Assessment |
9.1 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 United Kingdom (UK) Hereditary Angioedema Therapeutic Market - Competitive Landscape |
10.1 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Hereditary Angioedema Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Pricing
- Single User License$ 1,995
- Department License$ 2,400
- Site License$ 3,120
- Global License$ 3,795
Search
Related Reports
- Portugal Electronic Document Management Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
- France Electronic Document Management Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
- Portugal Occupational Health & Safety Services Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
- Netherlands Occupational Health and Safety Services Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
- Belgium and Luxembourg Facility Management Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
- Russia Women Intimate Apparel Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
- Africa Chocolate Market (2025-2031) | Size, Share, Trends, Growth, Revenue, Analysis, Forecast, industry & Outlook
- Global Hydroxychloroquine And Chloroquine Market (2025-2031) | Industry, Trends, Size, Outlook, Growth, Value, Companies, Revenue, Analysis, Share, Forecast
- Saudi Arabia Plant Maintenance Market (2025-2031) | Industry, Size, Growth, Revenue, Value, Companies, Forecast, Analysis, Share & Trends
- Taiwan Electric Truck Market (2025-2031) | Outlook, Industry, Revenue, Size, Forecast, Growth, Analysis, Share, Companies, Value & Trends
Industry Events and Analyst Meet
Industrial Facilities Management Expo 2025
4th Edition India Energy Conclave 2025
Media Expo 2025
Gas India Expo 2025
Consumer Electronics World Expo 2025
Our Clients
Whitepaper
- Middle East & Africa Commercial Security Market Click here to view more.
- Middle East & Africa Fire Safety Systems & Equipment Market Click here to view more.
- GCC Drone Market Click here to view more.
- Middle East Lighting Fixture Market Click here to view more.
- GCC Physical & Perimeter Security Market Click here to view more.
6WResearch In News
- Doha a strategic location for EV manufacturing hub: IPA Qatar
- Demand for luxury TVs surging in the GCC, says Samsung
- Empowering Growth: The Thriving Journey of Bangladesh’s Cable Industry
- Demand for luxury TVs surging in the GCC, says Samsung
- Video call with a traditional healer? Once unthinkable, it’s now common in South Africa
- Intelligent Buildings To Smooth GCC’s Path To Net Zero
